Fundraising FoxTorrey Pines Investment
Venture capitalSan Diego · Pre-Seed–Series A · 7 people tracked
Find your way into Torrey Pines Investment
Sign up to see every warm intro you have to Torrey Pines Investment
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Torrey Pines Investment team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Torrey Pines Investment concentrates on biotech and pharma opportunities, seeking assets capable of reaching clinical proof-of-concept within three years. The firm will lead, co-lead, or participate as a member of an investing syndicate. It aims to add value through development and regulatory strategy, drawing on in-house expertise spanning drug discovery, non-clinical and clinical studies, manufacturing, quality, and regulatory affairs. The firm also leverages the resources of its portfolio contract research organization (CRO) companies to support the product and corporate development of the companies it backs.
Source: firm website, verified Oct 26, 2026.
Team · 7 people
from the firm's website & public directories
Co-founder and Managing Member of Torrey Pines Investment, a serial entrepreneur and international investor in healthcare and IT for 30 years. His focus is life sciences, including drug design, drug discovery, and digital health. Holds an MS in physics and a Ph.D. in applied mathematics from the Moscow Institute of Physics and Technology and is the author of over 100 patents and publications.
Founding President of Torrey Pines Investment, responsible for strategic investments. Previously a biotech startup consultant, General Manager of Integrated Genomics, and held roles at The University of Chicago, including as a technology advisor to Arch Venture. Has 30 years of experience in the international life science industry and academia.
R&D Program Manager for the i2020 Accelerator, Inventor and Program Lead at Ensemble Mind, and founding principal of Infinity Web Digital Marketing. He leads scientific operations at Afraxis Inc., a San Diego CNS drug discovery company, with a research background in dendritic spine structure and synaptic plasticity.
Legal Counsel and co-founder/partner at Teal Ventures, an early-stage VC fund focused on digital/mobile health. A former partner at national law firms and corporate attorney in venture capital and M&A, he has advised startups and public companies across healthcare, medical devices, fintech, and e-commerce. Holds a JD from Stanford Law School and a BA from UCLA.
Head of the i2020 Accelerator with over 20 years of experience in key account and project management, business development, and sales for sustainable technologies and life sciences organizations. Holds an MSc and MBA and has extensive pharmaceutical industry and drug discovery experience.
Business development and licensing advisor for the i2020 Accelerator with over 25 years in life sciences, including senior management at executive and board levels. He has closed over 80 commercial deals, built alliances across pharma, biotech, and medtech, and developed entrepreneurship and biotech start-up courses internationally.
A biotechnology and pharmaceutical industry leader with over 35 years of experience, co-inventor on 35 issued US patents and co-author of over 150 scientific articles. Currently Senior Scientific Advisor for Vitruvean, Inc., he previously held executive roles at EnVivo Pharmaceuticals, NOVACE, Psychiatric Genomics, Scriptgen (Anadys), and Marion Merrell Dow Research Institute.
What they invest in
from 10 of 13 portfolio companiesBiotech ×8Healthtech ×7Medical Devices ×3AI & Machine Learning ×2Deep Tech ×2Digital Health ×2Marketing Tech ×1SaaS ×1
HQs:United States×5Finland×1
Investments · 13 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12018 · 12016 · 12014 · 15 dated
Context Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors.
BiotechHealthtechPhiladelphia, US
Martin Lehr(Founder)inJennifer Minai-Azary(Executive Officer)inAlex Levit(Executive Officer)Linda Beth West(Director)Richard Jay Berman(Director)Philip Kantoff(Director)in
Co-investorsNextech InvestOUP (Osage University Partners)
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.
AI & Machine LearningBiotechHealthtechDover, US
Megan McGill(Chief Executive Officer)inIain Dukes(Chief Business Officer / Chairman of the Board)inNikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)in
Co-investorsNew Enterprise Associates (NEA)OrbiMedBGV
i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.
BiotechDeep TechHealthtechSan Diego, US
Co-investorsBioGeneration VenturesOrbiMedBGV
19Labs builds GALE, a smart point-of-care platform that brings a full clinic experience to schools, rural communities, and pharmacies.
Digital HealthHealthtechMedical Devices
Ram Fish(Founder & CEO)inGerald Horel(Founder)in
Co-investorsTransPacific Venture Partners
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
Co-investorsAlexandria
Chromis Therapeutics is a biotech company with board members experienced in pharmaceutical development, corporate development, and healthcare investments.
BiotechHealthtechMedical DevicesSan Diego, US
BoardNikolay Savchuk(Chairman of the Board)Ronald Demuth(Director of the Board)Jennifer Giottonini Cayer(Director of the Board)
Elpida provides automated regulatory compliance monitoring for healthcare brands' digital communications.
AI & Machine LearningHealthtechMarketing TechSaaS
Co-investorsfresh.fundSkolkovo Foundation
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases.
BiotechDeep Tech
Timo(Scientific Co-founder)inErik(Scientific Co-founder)inSimon(Chief Executive Officer)inSebastian(Chief Operating Officer)in
Co-investorsInnovestor
Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.
Co-investorsOneVenturesR&D Tax IncentiveBrandon Capital
Viriom Inc. develops a pipeline of treatments for infectious diseases (blood-borne and respiratory viral diseases) and malignant diseases (solid tumors) through a global drug development platform built with partner networks.
Biotech
Co-investorsSkolkovo Foundation
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsContext TherapeuticsNASDAQ: CNTX
Frequently asked questions
- How many investments has Torrey Pines Investment made?
- Torrey Pines Investment has 13 tracked investments, 1 of which have exited.
- What stage does Torrey Pines Investment invest at?
- Torrey Pines Investment invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Torrey Pines Investment focus on?
- Torrey Pines Investment focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Torrey Pines Investment located?
- Torrey Pines Investment is headquartered in San Diego, US.
- Does Torrey Pines Investment lead rounds?
- Yes, Torrey Pines Investment leads investment rounds.
- Who does Torrey Pines Investment co-invest with?
- Torrey Pines Investment most often shares deals with Nextech Invest, OneVentures, OUP (Osage University Partners), among 4 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Golden Seeds is an angel investing network focused on funding and supporting early-stage, U.S.-based women-led startups across most industry sectors, while building a community of investors and providing investor education.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools, devices, biochemistry-based technologies, and digital health applications. It also builds companies of its own.